These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33233033)

  • 1. The Impact of Tiered-Pricing Framework on Generic Entry in Canada.
    Zhang W; Sun H; Guh DP; Lynd LD; Hollis A; Grootendorst P; Anis AH
    Int J Health Policy Manag; 2022 Jun; 11(6):768-776. PubMed ID: 33233033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.
    Wang Q; Liu S; Nie Z; Zhu Z; Fu Y; Zhang J; Wei X; Yang L; Wei X
    J Glob Health; 2023 Nov; 13():04137. PubMed ID: 37947028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of price-cap regulations on market entry by generic pharmaceutical firms.
    Zhang W; Sun H; Guh D; Anis AH
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):231-238. PubMed ID: 27936981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms.
    Zhang W; Guh D; Sun H; Marra CA; Lynd LD; Anis AH
    Med Care; 2016 Sep; 54(9):884-90. PubMed ID: 27213540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of European pharmaceutical price regulation on generic price competition: a review.
    Puig-Junoy J
    Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolution of Supply and Demand in Markets for Generic Drugs.
    Frank RG; McGuire TG; Nason I
    Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product-line extensions and pricing strategies of brand-name drugs facing patent expiration.
    Hong SH; Shepherd MD; Scoones D; Wan TT
    J Manag Care Pharm; 2005; 11(9):746-54. PubMed ID: 16300418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference pricing with endogenous generic entry.
    Brekke KR; Canta C; Straume OR
    J Health Econ; 2016 Dec; 50():312-329. PubMed ID: 27350294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering generic drug prices: less regulation equals more competition.
    Anis AH; Guh DP; Woolcott J
    Med Care; 2003 Jan; 41(1):135-41. PubMed ID: 12544550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Competition on Generic Drug Prices.
    Nguyen NX; Sheingold SH; Tarazi W; Bosworth A
    Appl Health Econ Health Policy; 2022 Mar; 20(2):243-253. PubMed ID: 34904207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are drug prices subject to creative destruction? Evidence from the US, 1997-2017.
    Lichtenberg FR
    Health Econ; 2021 Aug; 30(8):1910-1932. PubMed ID: 33987916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal price regulations in international pharmaceutical markets with generic competition.
    Geng D; Saggi K
    J Health Econ; 2020 May; 71():102315. PubMed ID: 32273046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do pharmaceutical prices rise anticipating branded competition?
    Ellyson AM; Basu A
    Health Econ; 2021 May; 30(5):1070-1081. PubMed ID: 33684255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prices for generics in Australia - more competition might help.
    Bulfone L
    Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Tiered Pricing Frameworks: A Simulation Approach.
    Moradpour J; Zhang W; Grootendorst P; Anis AH; Hollis A
    Value Health; 2023 Mar; 26(3):351-358. PubMed ID: 36396022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous versus exogenous generic reference pricing for pharmaceuticals.
    Antoñanzas F; Juárez-Castelló CA; Rodríguez-Ibeas R
    Int J Health Econ Manag; 2017 Dec; 17(4):413-432. PubMed ID: 28508248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
    Li DG; Joyce C; Mostaghimi A
    JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of regulated competition on pricing in Chinese pharmaceutical market under urban employee basic medical insurance.
    Zhao M; Wu J
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):311-320. PubMed ID: 27762144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.